US5502094A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use
Assignee: Hemagen PFC LP
•
Filing: 1995-05-17
•
Granted: 1996-03-26
•
Expires: 2015-05-17
Abstract
Abstract This invention relates to physiologically acceptable emulsions of perfluorocarbon ether hydrides having 8 to 12 carbon atoms. These novel emulsions have various medical applications. They are especially useful medically as contrast media for various biological imaging modalities such as nuclear magnetic resonance, 19 F-magnetic resonance imaging, ultrasound, x-ray, and computed tomography, as oxygen transport agents or "artificial bloods" in the treatment of heart attack, stroke, and other vascular obstructions, as adjuvants to coronary angioplasty and in cancer radiation treatment and chemotherapy.
Inventors
- 👤 George G. I. Moore
- 👤 Richard M. Flynn
- 👤 Miguel A. Guerra
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-31 18:55
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0026; A61K49/00; A61K49/04; A61K49/0433; A61K49/0447; A61K49/0461; A61K49/06; A61K49/18; A61K49/1806; A61K49/22; A61K49/222; A61K49/226; A61P; A61P35/00; A61P9/00; A61P9/08; A61P9/10; A62; A62D; A62D1/00; A62D1/0028; A62D1/0035; B; B01; B01D; B01D12/00; B23; B23K; B23K35/00; B23K35/22; B23K35/38; B23K35/386; C; C07; C07C; C07C41/00; C07C41/01; C07C41/18; C07C41/24; C07C41/48; C07C43/00; C07C43/02; C07C43/03; C07C43/04; C07C43/12; C07C43/123; C07C43/126; C07C43/18; C07C43/192; C07C43/30; C07C43/313; C07C59/00; C07C59/125; C07C59/135; C07C69/00; C07C69/66; C07C69/67; C07C69/708; C07D; C07D319/00; C07D319/04; C07D319/06; C07C2601/00; C07C2601/12; C07C2601/14; C08; C08J; C08J2203/00; C08J2203/14; C08J2203/146
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
71 words
A physiologically acceptable aqueous emulsion comprising a saturated C 8 to C 12 perfluorocarbon ether hydride selected from the group consisting of a hydroperfluoroaliphatic ether, a hydroperfluoroaliphatic ether substituted with a perfluoroalicyclic group, and a hydroperfluorocycloaliphatic ether and mixtures thereof, wherein said aliphatic ether has a straight-chain or a branched-chain of carbon atoms, water and a surfactant, wherein the components are contained in the emulsion in amounts for acceptable physiological administration.
Claim 2
Dependent Claim
71 words
A physiologically acceptable aqueous emulsion comprising a saturated C 8 to C 12 perfluorocarbon ether hydride selected from the group consisting of a hydroperfluoroaliphatic ether, a hydroperfluoroaliphatic ether substituted with a perfluoroalicyclic group, and a hydroperfluorocycloaliphatic ether and mixtures thereof, wherein said aliphatic ether has a straight-chain or a branched-chain of carbon atoms, water and a surfactant, wherein the components are contained in the emulsion in amounts for acceptable physiological administration.
Claim 3
Dependent Claim
15 words
The emulsion of claim 1 wherein said ether is C 9 to C 11 .
Claim 4
Dependent Claim
18 words
The emulsion of claim 1 wherein said ether has a boiling point of at least about 120° C.
Claim 5
Dependent Claim
112 words
The emulsion of claim 1 wherein said ether is represented by the formula: X-R.sub.f -O(R.sub.f '-O).sub.n R.sub.f "-H wherein: H is a primary hydrogen atom or a 2° hydrogen atom on a carbon adjacent to an ether oxygen atom; X is a fluorine atom or a primary hydrogen atom, or a 2° hydrogen atom on a carbon adjacent to an ether oxygen atom; n is an integer of 0 to 4; and R f , R f ' and R f " are independently selected from unbranched or branched groups consisting of perfluoroalkylene, perfluorocycloalkylene, or perfluorocycloalkylene containing one or more ether oxygens, and which groups may be substituted with an ether oxygen.
Claim 6
Dependent Claim
16 words
The emulsion of claim 1 wherein said ether is a C 9 -C 10 dihydroperfluorocarbon ether.
Claim 7
Dependent Claim
110 words
The emulsion of claim 5 wherein said ether is selected from the group consisting of H-C 3 F 6 OC 4 F 8 OC 3 F 6 -H, H-C 2 F 4 OCF 2 C(CF 3 ) 2 CF 2 OC 2 F 4 -H, H-C 2 F 4 -O-(CF 2 ) 5 -O-C 2 F 4 -H, H-C 2 F 4 -O-(CF 2 ) 6 -O-C 2 F 4 -H, H-CF 2 O-(C 2 F 4 O) 3 CF 2 -H, H-CF 2 O-(C 2 F 4 O) 4 CF 2 -H and H-C 2 F 4 -O-cyclo-C 6 F 10 -O-C 2 F 4 -H, and mixtures thereof.
Claim 8
Dependent Claim
27 words
The emulsion of claim 1 wherein said ether is a C 9 -C 11 perfluorocycloalkyl ether hydride or a C 9 -C 11 perfluorocycloalkyl-substituted perfluoroalkylene ether hydride.
Claim 9
Dependent Claim
19 words
The emulsion of claim 7 wherein said ether is selected from the group consisting of ##STR13## and mixtures thereof.
Claim 10
Dependent Claim
48 words
The emulsion of claim 1 wherein said ether is a C 9 -C 10 hydroperfluoroalkyl ethers where the hydrogen atom is 1° or is 2° bonded to a carbon atom adjacent to an ether oxygen either bonded to an end carbon or intermediate carbon adjacent to an ether.
Claim 11
Dependent Claim
19 words
The emulsion of claim 9 wherein said ether is selected from the group consisting of ##STR14## and mixtures thereof.
Claim 12
Dependent Claim
24 words
The emulsion of claim 1 wherein the surfactant is present in an amount from about 0.5 to about 10% by weight of the emulsion.
Claim 13
Dependent Claim
24 words
The emulsion of claim 1 wherein the surfactant is present in an amount from about 1 to about 4% by weight of the emulsion.
Claim 14
Dependent Claim
24 words
The emulsion of claim 1 wherein the ether is present in an amount from about 10 to about 75% by volume of the emulsion.
Claim 15
Dependent Claim
24 words
The emulsion of claim 13 wherein a surfactant is contained in an amount from about 0.5 to about 10% by weight of the emulsion.
Claim 16
Dependent Claim
24 words
The emulsion of claim 1 wherein the said ether is contained in an amount of at least about 40% by volume of the emulsion.
Claim 17
Dependent Claim
11 words
The emulsion according to claim 1 wherein the surfactant is lecithin.
Claim 18
Dependent Claim
23 words
An emulsion according to claim 16 further comprising a physiologically acceptable oil that is not substantially surface active and not significantly water soluble.
Claim 19
Dependent Claim
21 words
The emulsion according to claim 17 wherein the oil is selected from the group consisting of safflower oil and soybean oil.
Claim 20
Dependent Claim
29 words
The emulsion according to claim 1 further comprising at least one compound selected from the group consisting of isotonic agents, osmotic pressure controlling agents, serum extending agents and antioxidants.
References Cited (Backward Citations)
US3493581A
Cited
US3911138A
Cited
US3911138B1
Cited
US3962439A
Cited
DE2650586A1
Cited
GB1549038A
Cited
US4110474A
Cited
US4187252A
Cited
US4186253A
Cited
US4252827A
Cited
US4443480A
Cited
US4423077A
Cited
US4534978A
Cited
EP0158996A2
Cited
US4686024A
Cited
US4868318A
Cited
US4865836A
Cited
EP0231091A1
Cited
US4866096A
Cited
WO1989010118A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-03-26 | 1999-09-25 | 2000-03-26 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-03-26 | 2003-09-25 | 2004-03-26 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-03-26 | 2007-09-25 | 2008-03-26 | $7700.00 | Window Closed / Lapsed |